HEMOGENYX PHARMACEUTICALS PLC
HEMO | IL
Overview
Corporate Details
- ISIN(s):
- GB00BYX3WZ24
- LEI:
- 2138008L93GYU5GN6179
- Country:
- United Kingdom
- Address:
- 6TH FLOOR, 60 GRACECHURCH STREET, EC3V 0HR LONDON
- Website:
- https://hemogenyx.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Hemogenyx Pharmaceuticals PLC develops therapies for blood diseases and bone marrow transplantation.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-03 15:02 |
Share Issue/Capital Change
Placing to Raise £451,250 and Director’s Dealing
|
English | 26.1 KB | |
| 2025-06-03 08:00 |
Regulatory News Service
Second Patient Passes Initial Safety Tests
|
English | 14.9 KB | |
| 2025-05-31 12:30 |
Declaration of Voting Results & Voting Rights Announcements
Resolutions passed at Annual General Meeting of Hemogenyx Pharmaceuticals plc o…
|
English | 33.9 KB | |
| 2025-05-29 15:06 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 27.1 KB | |
| 2025-05-20 21:50 |
Annual Report (ESEF)
Annual Report & Financial Statements for the Year Ended 31 December 2024
|
English | 673.1 KB | |
| 2025-05-20 21:50 |
Annual Report
Annual Report & Financial Statements for the Year Ended 31 December 2024
|
English | 2.4 MB | |
| 2025-05-14 08:00 |
Regulatory News Service
Pediatric Amendment to Clinical Protocol
|
English | 11.0 KB | |
| 2025-05-02 17:24 |
AGM Report
Notice of AGM
|
English | 11.5 KB | |
| 2025-04-29 00:59 |
Annual Report
Annual Report & Financial Statements for the Year Ended 31 December 2024
|
English | 1.3 MB | |
| 2025-03-17 08:00 |
Regulatory News Service
Recruitment of Second Patient for Clinical Trials
|
English | 11.9 KB | |
| 2025-03-13 16:10 |
Regulatory News Service
Conversion of convertible loan notes
|
English | 10.1 KB | |
| 2025-03-11 08:00 |
Regulatory News Service
Institutional investment
|
English | 12.6 KB | |
| 2025-02-24 08:00 |
Regulatory News Service
First-in-Human Treatment with HG-CT-1
|
English | 13.2 KB | |
| 2025-02-19 17:50 |
Regulatory News Service
Issue of convertible loan notes
|
English | 14.2 KB | |
| 2025-01-31 10:35 |
Regulatory News Service
Total Voting Rights
|
English | 10.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
European Institute of Science AB | Sweden | EURI B | |
|
European Medical Solutions | Belgium | ALEMS | |
|
Evogene Ltd. | Israel | EVGN | |
|
Evolva Holding SA | Switzerland | EVE | |
|
EXACT Therapeutics AS | Norway | EXTX | |
|
Exosens | France | EXENS | |
|
ExpreS2ion Biotech Holding AB | Sweden | EXPRS2 | |
|
Fermentalg | France | ALGAE | |
|
Formycon AG | Germany | FYB | |
|
FRONTIER IP GROUP PLC | United Kingdom | FIPP |